- Developed the early commercial plan for a pipeline asset, enriching commercial insights to shape the future environment and increase probability for a differentiated launch for a $6.9B market opportunity- Executed congress strategy at eight scientific conferences, including identification of titles of interest, analysis of competitor activities, engagement with key customers and internal dissemination of key insights- Carried out marketing strategies by overseeing the internal review process and partnering with external agencies to develop promotional materials for conferences and medical education - Validated franchise narrative and understanding of the pneumococcal landscape through engagement with the Commercial Advisory Panel, resulting in the generation of three strategic deliverables - Developed and disseminated 10 scientific strategy resources focusing on epidemiology, disease burden impacts, serotype-specific information and population analysis to drive strategic intent - Championed franchise-level initiatives including coordinating priorities, developing strategic materials and building an franchise overview for all onboarding and alignment across HQ and global markets- Served as a strategic partner to the VAXNEUVANCE Team, updating the global strategy to win against new competitors

- Guided commercial strategy through competitive intelligence activity, creating competitor product profiles for seven rare disease indications- Led hospital discharge data analysis to obtain epidemiologic insights to support forecasting and enhance publication strategy through publishing one manuscript and three poster- Analyzed clinical data and secondary resources to determine scientific viability of novel disease states and support development of trial design

- Built a target value proposition using scientific and patient perspective insights for a genomics medicine asset- Elevated the differentiation profile of an early stage, rare disease asset via literature searches and social media listening- Segmented and targeted subpopulations of high unmet need and corresponding place in therapy, including careful consideration of diversity, equity and inclusion, through creation of patient narratives for three rare disease programs

- Generated strategic recommendations using user demographics and behaviors from the Precision Health and Genomics Knowledge Base (PHGKB) and My Family Health Portrait (MFHP) extracted via Google Analytics

- Produced a medical learning & development curriculum for treatment landscape of a premarket indication- Collaborated closely with marketing and HEOR colleagues across multiple activities, including refinement of promotional language and development of economic research models